For the first time in a year, a panel tasked with helping to direct nearly $2 billion in autism funds was supposed to meet, but now the gathering has been abruptly called off and it's unclear why.

Months after Trump administration officials promoted a medication as a possible treatment for autism, the FDA is expanding ...

Advocates are working with some of the nation's most recognizable companies in an effort to increase disability access in ...

Prescriptions for a medication touted as a possible treatment for autism surged while Tylenol use among pregnant women plummeted after Trump administration officials made claims about both.

New data shows that the number of U.S. children eligible for services under the Individuals with Disabilities Education Act ...

After U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. remade a key federal autism panel, some of the nation's most influential researchers and advocates are creating a competing one.

A team of neurodiverse individuals is launching what they're billing as a first-of-its-kind advertising agency.

As the U.S. Department of Education accelerates efforts to dismantle the agency, the implications for students with disabilities remain murky.

President Donald Trump’s nominee to be the nation’s top doctor said she’s not ready to rule out anything — including vaccines — in determining what’s behind rising autism rates. Members of the U.S.

Months after Trump administration officials hyped a drug as a possible treatment for autism symptoms, one of the largest studies examining its effectiveness in this population has been retracted. The ...

A one-of-a-kind museum chronicling disability history is reopening after a five-year hiatus in a new, bigger space that’s hundreds of miles away from its previous home. The Museum of Disability ...